Relationship between the expression of VEGF signal components and matrix metalloproteinases in ovarian tumors

Bulletin of Experimental Biology and Medicine

Volumn 151, Issue 4, 2011, Pages 449-453

  Gershtein, E S ^a   Kushlinsky, D N ^b   Levkina, N V ^a   Tereshkina, I V ^a   Nosov, V B ^b   Laktionov, K P ^a   Adamyan, L V ^b  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b RESEARCH CENTER OF OBSTETRICS   (Russian Federation)

Author keywords

Matrix metalloproteinase; Ovarian tumors; Vascular endothelial growth factor; Vascular endothelial growth factor receptor

Indexed keywords

GELATINASE A; GELATINASE B; MATRILYSIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ARTICLE; BENIGN TUMOR; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; OVARY CANCER; PRIMARY TUMOR; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

FEMALE; HUMANS; MATRIX METALLOPROTEINASES; OVARIAN NEOPLASMS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80555146006     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-011-1353-5     Document Type: Article

References (15)

1. E. S. Gershtein, N. V. Levkina, M. A. Digaeva, et al., Byull. Eksp. Biol. Med., 149, No. 5, 562-565 (2010).
2. P. G. Artini, M. Ruggiero, P. Monteleone, et al., Biomed. Pharmacother., 62, No. 6, 373-377 (2008).
3. D. Belotti, C. Calcagno, A. Garofalo, et al., Mol. Cancer Res., 6, No. 4, 525-534 (2008).
4. D. Belotti, P. Paganoni, L. Manenti, et al., Cancer Res., 63, No. 17, 5224-5229 (2003).
5. K. Q. Cai, W. L. Yang, C. D. Capo-Chichi, et al., Mol. Carcinog., 46, No. 2, 130-143 (2007).
6. H. Chen, D. Ye, X. Xie, et al., Gynecol. Oncol., 94, No. 3, 630-635 (2004).
7. F. J. Collinson, G. D. Hall, T. J. Perren, and G. C. Jayson, Expert. Rev. Anticancer Ther., 8, No. 1, 21-32 (2008).
8. B. Davidson, I. Goldberg, W. H. Gotlieb, et al., Mol. Cell Endocrinol., 187, Nos. 1-2, 39-45 (2002).
9. E. I. Deryugina and J. P. Quigley, Biochim. Biophys. Acta, 1803, No. 1, 103-120 (2010).
10. P. Karihtala, J. Mäenpää, T. Turpeenniemi-Hujanen, and U. Puistola, Anticancer Res., 30, No. 3, 1001-1006 (2010).
11. W. Lu, H. Chen, F. Yel, et al., Eur. J. Gynaecol. Oncol., 27, No. 4, 363-369 (2006).
12. S. Sillanpaa, M. Anttila, K. Suhonen, et al., Tumour Biol., 28, No. 5, 280-289 (2007).
13. S. Sillanpaa, M. Anttila, K. Voutilainen, et al., Gynecol. Oncol., 104, No. 2, 296-303 (2007).
14. F. Q. Wang, J. So, S. Reierstad, and D. A. Fishman, Int. J. Cancer, 118, No. 4, 879-888 (2006).
15. F. Q. Wang, J. So, S. Reierstad, and D. A. Fishman, Int. J. Cancer, 114, No. 1, 19-31 (2005).